Erlotinib Hydrochloride

Erlotinib Hydrochloride
Trade Name Tarceva
Orphan Indication Malignant gliomas
USA Market Approval USA
USA Designation Date 2003-07-18 00:00:00
Sponsor Genentech, Inc;1 DNA Way;South San Francisco, California, 94080